Kenneth C. Carter, President and CEO at AVALON PHARMACEUTICALS INC (AVRX), sold 2,032 shares at $2.45 ($5K) on 2008-01-17, disclosed to the SEC on 2008-01-23.
Open-market sale of $5k AVRX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.45 | 732 | $2K | 34.9% |
| 2 | $2.50 | 300 | $750 | 14.6% |
| 3 | $2.53 | 200 | $506 | 9.8% |
| 4 | $2.58 | 200 | $516 | 10.0% |
| 5 | $2.63 | 400 | $1K | 20.4% |
| 6 | $2.64 | 200 |
| $528 |
| 10.3% |
| Total | $2.53 avg | 2,032 | $5K | 100% |
| Filing → |
| AVRX | BUY | 2006-08-24 | $7K | — | Filing → |